Phase I/II Study of Carfilzomib, Pomalidomide and Dexamethasone in Relapsed And/Or Refractory Multiple Myeloma Patients (CPD)
Clinical trial NCT02185820 · COMPLETED
Trial details
- NCT number
- NCT02185820
- Sponsor
- European Myeloma Network B.V.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-01
- Primary completion
- 2015-07-01
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.